In this next episode of The Heidrick & Struggles Leadership Podcast, Heidrick & Struggles’ Andy MacLeod speaks to Mathai Mamman, the CEO of FogPharma, a company spun out of Harvard University with a mission to drastically reduce the burden of disease on patients and their families by inventing new types of drugs. Previously, Mammen was a member of the executive committee at Johnson & Johnson, where he served as executive vice president of pharmaceutical R&D. In this conversation, Mammen discusses balancing steady, incremental innovation and significant, transformational innovation, and how leaders should leaders think about that balance as they plot their strategic agenda and build their teams. He also discusses the development of Johnson & Johnson’s Covid-19 vaccine, creating value as a purpose-driven company, and what he views as the consistent traits and skills business leaders need to possess that enable them to harness science and innovation impactfully. Hosted on Acast. See acast.com/privacy for more information.